Cyteir Therapeutics

+$0.91 (+5.10%) Today
-$0.11 (-0.59%) As of 8:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CYT and other ETFs, options, and stocks.

About CYT

Cyteir Therapeutics, Inc. engages in the development of novel therapeutics and deoxyribonucleic acid repair and synthetic lethal therapies. It exploits the synthetic lethality of gain-of-function DNA-damaging genes and DNA repair inhibition, resulting in selective death among cells.

CEO
Markus F. Renschler
Employees
25
Headquarters
Lexington, Massachusetts
Founded
2012

CYT Key Statistics

Market Cap
663.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
45.53K
High Today
$18.97
Low Today
$17.75
Open Price
$17.75
Volume
305.15K
52 Week High
$23.10
52 Week Low
$14.00

CYT Earnings

-$4.83
-$3.22
-$1.61
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure